Cystatin C: A New Renal Marker and Its Potential Use in Small Animal Medicine

Journal of Veterinary Internal Medicine

Volumn 28, Issue 4, 2014, Pages 1152-1164

  Ghys, L ^a   Paepe, D ^a   Smets, P ^a   Lefebvre, H ^b   Delanghe, J ^a   Daminet, S ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Cat; Dog; Glomerular filtration rate; Human; Renal diseases

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN C;

ANIMAL; BLOOD; CAT; CAT DISEASES; DOG; DOG DISEASES; GLOMERULUS FILTRATION RATE; HUMAN; RENAL INSUFFICIENCY, CHRONIC; VETERINARY;

ANIMALS; BIOLOGICAL MARKERS; CAT DISEASES; CATS; CYSTATIN C; DOG DISEASES; DOGS; GLOMERULAR FILTRATION RATE; HUMANS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84904250171     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/jvim.12366     Document Type: Review

References (177)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-2047.
2. Lulich JP, Osborne CA, Obrien TD, et al. Feline renal failure - Questions, answers, questions. Comp Cont Educ Pract 1992;14:127-151.
3. Lund EM, Armstrong PJ, Kirk CA, et al. Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States. J Am Vet Med Assoc 1999;214:1336-1341.
4. DiBartola SP, Rutgers HC, Zack PM, et al. Clinicopathologic findings associated with chronic renal disease in cats: 74 cases (1973-1984). J Am Vet Med Assoc 1987;190:1196-1202.
5. Boyd LM, Langston C, Thompson K, et al. Survival in cats with naturally occurring chronic kidney disease (2000-2002). J Vet Intern Med 2008;22:1111-1117.
6. Braun JP, Lefebvre HP. Kidney function and damage. Kaneko JJ, Harvey JW, Bruss ML, ed. Clinical Biochemistry of Domestic Animals, 6th ed. London: Elsevier; 2008:485-528.
7. Paepe D, Daminet S. Feline CKD: Diagnosis, staging and screening- what is recommended? J Feline Med Surg 2013;15:15-27.
8. Abrahamson M, Olafsson I, Palsdottir A, et al. Structure and expression of the human cystatin C gene. Biochem J 1990;268:287-294.
9. Jacobsson B, Lignelid H, Bergerheim USR. Transthyretin and cystatin C are catabolized in proximal tubular epihtelial cells and the proteins are not useful as markers for renal cell carcinomas. Histopathology 1995;26:559-564.
10. Tenstad O, Roald AB, Grubb A, et al. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 1996;56:409-414.
11. Kaseda R, Iino N, Hosojima M, et al. Megalin-mediated endocytosis of cystatin C in proximal tubule cells. Biochem Biophys Res Commun 2007;357:1130-1134.
12. Seronie-Vivien S, Delanaye P, Pieroni L, et al. Cystatin C: Current position and future prospects. Clin Chem Lab Med 2008;46:1664-1686.
13. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis 2002;40:221-226.
14. Conti M, Moutereau S, Zater M, et al. Urinary cystatin C as a specific marker of tubular dysfunction. Clin Chem Lab Med 2006;44:288-291.
15. Uchida K, Gotoh A. Measurement of cystatin-C and creatinine in urine. Clin Chim Acta 2002;323:121-128.
16. Clausen J. Proteins in normal cerebrospinal fluid not found in serum. Proc Soc Exp Biol Med 1961;107:170-172.
17. Butler EA, Flynn FV. The occurrence of post-gamma protein in urine: A new protein abnormality. J Clin Pathol 1961;14:172-178.
18. Lofberg H, Grubb AO. Quantitation of gamma-trace in human biological fluids: Indications for production in the central nervous system. Scand J Clin Lab Invest 1979;39:619-626.
19. Grubb A, Lofberg H. Human gamma-trace, a basic microproteAmino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci USA 1982;79:3024-3027.
20. Moller CA, Lofberg H, Grubb AO, et al. Distribution of cystatin C (gamma-trace), an inhibitor of lysosomal cysteine proteinases, in the anterior lobe of simian and human pituitary glands. Neuroendocrinology 1985;41:400-404.
21. Colle A, Tonnelle C, Jarry T, et al. Isolation and characterization of post gamma globulin in mouse. Biochem Biophys Res Commun 1984;122:111-115.
22. Barrett AJ, Davies ME, Grubb A. The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Commun 1984;120:631-636.
23. Bobek LA, Levine MJ. Cystatins-inhibitors of cysteine proteinases. Crit Rev Oral Biol Med 1992;3:307-332.
24. Grubb A, Simonsen O, Sturfelt G, et al. Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand 1985;218:499-503.
25. Simonsen O, Grubb A, Thysell H. The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest 1985;45:97-101.
26. Kyhse-Andersen J, Schmidt C, Nordin G, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994;40:1921-1926.
27. Sohrabian A, Noraddin FH, Flodin M, et al. Particle enhanced turbidimetric immunoassay for the determination of urine cystatin C on Cobas c501. Clin Biochem 2012;45:339-344.
28. Finney H, Newman DJ, Gruber W, et al. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997;43:1016-1022.
29. Herget-Rosenthal S, Feldkamp T, Volbracht L, et al. Measurement of urinary cystatin C by particle-enhanced nephelometric immunoassay: Precision, interferences, stability and reference range. Ann Clin Biochem 2004;41:111-118.
30. Mussap M, Ruzzante N, Varagnolo M, et al. Quantitative automated particle-enhanced immunonephelometric assay for the routinary measurement of human cystatin C. Clin Chem Lab Med 1998;36:859-865.
31. Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II system. Scand J Clin Lab Invest 1999;59:1-8.
32. Flodin M, Hansson LO, Larsson A. Variations in assay protocol for the Dako cystatin C method may change patient results by 50% without changing the results for controls. Clin Chem Lab Med 2006;44:1481-1485.
33. Newman DJ, Thakkar H, Edwards RG, et al. Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995;47:312-318.
34. Garrido MJ, Hermida J, Tutor JC. Immunoturbidimetric assay for serum cystatin C using the Cobas Fara analyzer. Clin Chem Lab Med 2002;40:853-854.
35. Al-Turkmani MR, Law T, Kellogg MD. Performance evaluation of a particle-enhanced turbidimetric cystatin C assay on the Hitachi 917 analyzer. Clin Chim Acta 2008;398:75-77.
36. Conde-Sanchez M, Roldan-Fontana E, Chueca-Porcuna N, et al. Analytical performance evaluation of a particle-enhanced turbidimetric cystatin C assay on the Roche COBAS 6000 analyzer. Clin Biochem 2010;43:921-925.
37. Flodin M, Larsson A. Performance evaluation of a particle-enhanced turbidimetric cystatin C assay on the Abbott ci8200 analyzer. Clin Biochem 2009;42:873-876.
38. Delanghe JR, Cobbaert C, Harmoinen A, et al. Focusing on the clinical impact of standardization of creatinine measurements: A report by the EFCC Working Group on Creatinine Standardization. Clin Chem Lab Med 2011;49:977-982.
39. Grubb A, Blirup-Jensen S, Lindstrom V, et al. First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med 2010;48:1619-1621.
40. Myers GL. Standardization of serum creatinine measurement: Theory and practice. Scand J Clin Lab Invest 2008;68:57-63.
41. Myers GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: A report from the laboratory working group of the National Kidney Disease Education Program. Clin Chem 2006;52:5-18.
42. Nakata J, Nakahari A, Takahashi C, et al. Molecular cloning, expression in Escherichia coli, and development of monoclonal antibodies to feline cystatin C. Vet Immunol Immunopathol 2010;138:231-234.
43. Pearson WR, Wood T, Zhang Z, et al. Comparison of DNA sequences with protein sequences. Genomics 1997;46:24-36.
44. Poulik MD, Shinnick CS, Smithies O. Partial amino-acid-sequences of human and dog post-gamma-globulins. Mol Immunol 1981;18:569-572.
45. Uchida K, Kuroki K, Yoshino T, et al. Immunohistochemical study of constituents other than beta-protein in canine senile plaques and cerebral amyloid angiopathy. Acta Neuropathol 1997;93:277-284.
46. Jensen AL, Bomholt M, Moe L. Preliminary evaluation of a particle-enhanced turbidimetric immunoassay (PETIA) for the determination of serum cystatin C-like immunoreactivity in dogs. Vet Clin Pathol 2001;30:86-90.
47. Braun JP, Perxachs A, Péchereau D, et al. Plasma cystatin C in the dog: Reference values and variations with renal failure. Comp Clin Pathol 2002;11:44-49.
48. Almy FS, Christopher MM, King DP, et al. Evaluation of cystatin C as an endogenous marker of glomerular filtration rate in dogs. J Vet Intern Med 2002;16:45-51.
49. Gonul R, Kayar A, Or ME, et al. Assessment of renal function in dogs with renal disease using serum cystatin C. Indian Vet J 2004;81:872-874.
50. Antognoni MT, Siepi D, Porciello F, et al. Use of serum cistatin C determination as a marker of renal function in the dog. Vet Res Commun 2005;29(Suppl 2):265-267.
51. Wehner A, Hartmann K, Hirschberger J. Utility of serum cystatin C as a clinical measure of renal function in dogs. J Am Anim Hosp Assoc 2008;44:131-138.
52. Monti P, Benchekroun G, Berlato D, et al. Initial evaluation of canine urinary cystatin C as a marker of renal tubular function. J Small Anim Pract 2012;53:254-259.
53. Miyagawa Y, Takemura N, Hirose H. Evaluation of the measurement of serum cystatin C by an enzyme-linked immunosorbent assay for humans as a marker of the glomerular filtration rate in dogs. J Vet Med Sci 2009;71:1169-1176.
54. Ghys L, Meyer E, Paepe D, et al. Analytical validation of the particle-enhanced nephelometer for measurement of Cystatin C in feline serum and urine. Vet Clin Pathol 2013. DOI:10.1111/vcp.12144
55. Shah VP, Midha KK, Findlay JW, et al. Bioanalytical method validation-a revisit with a decade of progress. Pharm Res 2000;17:1551-1557.
56. Jonkisz P, Kungl K, Sikorska A, et al. Cystatin C analysis in the dog: A comparison of turbidimetric and nephelometric assay results. Acta Vet Hung 2010;58:59-67.
57. Newman DJ, Price CP. Renal function and nitrogen metabolites. Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. Philadelphia, PA: WB Saunders; 1998:1204-1270.
58. Breckenbridge A, Metcalfe-Gibson A. Methods for measuring glomerular filtration rate: A comparison of inulin, vitamin B12 and creatinine clearance. Lancet 1965;2:265-267.
59. Sigman EM, Elwood CM, Knox F. The measurement of glomerular filtration rate in man with sodium iothalamate 131-I (Conray). J Nucl Med 1966;7:60-68.
60. Mak RH, Haycock GB, Chantler C. Glucose intolerance in children with chronic renal failure. Kidney Int Suppl 1983;15:S22-S26.
61. Chantler C, Barratt TM. Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid. Arch Dis Child 1972;47:613-617.
62. Hilson AJ, Mistry RD, Maisey MN. 99Tcm-DTPA for the measurement of glomerular filtration rate. Br J Radiol 1976;49:794-796.
63. Krutzen E, Back SE, Nilsson-Ehle I, et al. Plasma clearance of a new contrast agent, iohexol: A method for the assessment of glomerular filtration rate. J Lab Clin Med 1984;104:955-961.
64. Finco DR, Tabaru H, Brown SA, et al. Endogenous creatinine clearance measurement of glomerular filtration rate in dogs. Am J Vet Res 1993;54:1575-1578.
65. Blythe WB. The endogenous creatinine clearance. Am J Kidney Dis 1982;2:321-323.
66. James GD, Sealey JE, Alderman M, et al. A longitudinal study of urinary creatinine and creatinine clearance in normal subjects. Race, sex, and age differences. Am J Hypertens 1988;1:124-131.
67. Levey AS, Berg RL, Gassman JJ, et al. Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int Suppl 1989;27:S73-S80.
68. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem 1992;38:1933-1953.
69. DiBartola SP. Clinical approach and laboratory evaluation of renal disease. Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. Philadelphia, PA: WB Saunders; 2010:1955-1969.
70. Polzin DJ. Chronic kidney disease. Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine, 7th ed. Philadelphia, PA: WB Saunders; 2010:1990-2021.
71. Vinge E, Lindergard B, Nilsson-Ehle P, et al. Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest 1999;59:587-592.
72. Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000;36:29-34.
73. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
74. Counahan R, Chantler C, Ghazali S, et al. Estimation of glomerular filtration rate from plasma creatinine concentration in children. Arch Dis Child 1976;51:875-878.
75. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612.
76. Schwartz GJ, Haycock GB, Edelman CM, et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976;58:259-263.
77. Shull BC, Haughey D, Koup JR, et al. A useful method for predicting creatinine clearance in children. Clin Chem 1978;24:1167-1169.
78. Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009;20:629-637.
79. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003;18:2024-2031.
80. Hojs R, Bevc S, Ekart R, et al. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant 2006;21:1855-1862.
81. Hojs R, Bevc S, Ekart R, et al. Kidney function estimating equations in patients with chronic kidney disease. Int J Clin Pract 2011;65:458-464.
82. Sjostrom P, Tidman M, Jones I. Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest 2005;65:111-124.
83. Ma YC, Zuo L, Chen JH, et al. Improved GFR estimation by combined creatinine and cystatin C measurements. Kidney Int 2007;72:1535-1542.
84. Tidman M, Sjostrom P, Jones I. A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two. Nephrol Dial Transplant 2008;23:154-160.
85. Keevil BG, Kilpatrick ES, Nichols SP, et al. Biological variation of cystatin C: Implications for the assessment of glomerular filtration rate. Clin Chem 1998;44:1535-1539.
86. Horio M, Imai E, Yasuda Y, et al. Performance of serum cystatin C versus serum creatinine as a marker of glomerular filtration rate as measured by inulin renal clearance. Clin Exp Nephrol 2011;15:868-876.
87. Schuck O, Teplan V, Jabor A, et al. Glomerular filtration rate estimation in patients with advanced chronic renal insufficiency based on serum cystatin C levels. Nephron Clin Pract 2003;93:c146-c151.
88. Eriksen BO, Mathisen UD, Melsom T, et al. Cystatin C is not a better estimator of GFR than plasma creatinine in the general population. Kidney Int 2010;78:1305-1311.
89. Antognoni MT, Siepi D, Porciello F, et al. Serum cystatin-C evaluation in dogs affected by different diseases associated or not with renal insufficiency. Vet Res Commun 2007;31(Suppl 1):269-271.
90. Pagitz M, Frommlet F, Schwendenwein I. Evaluation of biological variance of cystatin C in comparison with other endogenous markers of glomerular filtration rate in healthy dogs. J Vet Intern Med 2007;21:936-942.
91. Petersen PH, Fraser CG, Sandberg S, et al. The index of individuality is often a misinterpreted quantity characteristic. Clin Chem Lab Med 1999;37:655-661.
92. Martin C, Péchereau D, De la Farge F, et al. Cystatine C plasmatique chez le chat: Les technique actuelles ne permettent pas de l'utiliser comme marqueur d'insufficance rénale. Revue Médicine Vétérinaire 2002;153:305-310.
93. Friedrichs KR, Harr KE, Freeman KP, et al. ASVCP reference interval guidelines: Determination of de novo reference intervals in veterinary species and other related topics. Vet Clin Pathol 2012;41:441-453.
94. Poswiatowska-Kaszczyszyn I. Usefulness of serum cystatin C measurement for assessing renal function in cats. Bull Vet Inst Pulawy 2012;56:235-239.
95. Al-Tonbary YA, Hammad AM, Zaghloul HM, et al. Pretreatment cystatin C in children with malignancy: Can it predict chemotherapy-induced glomerular filtration rate reduction during the induction phase? J Pediatr Hematol Oncol 2004;26:336-341.
96. Bokenkamp A, Domanetzki M, Zinck R, et al. Cystatin C-a new marker of glomerular filtration rate in children independent of age and height. Pediatrics 1998;101:875-881.
97. Nitta K, Hayashi T, Uchida K, et al. Serum cystatin C concentration as a marker of glomerular filtration rate in patients with various renal diseases. Intern Med 2002;41:931-935.
98. Randers E, Kristensen JH, Erlandsen EJ, et al. Serum cystatin C as a marker of the renal function. Scand J Clin Lab Invest 1998;58:585-592.
99. Risch L, Blumberg A, Huber A. Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C. Nephrol Dial Transplant 1999;14:1991-1996.
100. Stickle D, Cole B, Hock K, et al. Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population. Clin Chem 1998;44:1334-1338.
101. Heiene R, Moe L. Pharmacokinetic aspects of measurement of glomerular filtration rate in the dog: A review. J Vet Intern Med 1998;12:401-414.
102. Finch NC, Syme HM, Elliott J, et al. Glomerular filtration rate estimation by use of a correction formula for slope-intercept plasma iohexol clearance in cats. Am J Vet Res 2011;72:1652-1659.
103. Roald AB, Aukland K, Tenstad O. Tubular absorption of filtered cystatin-C in the rat kidney. Exp Physiol 2004;89:701-707.
104. Kabanda A, Jadoul M, Lauwerys R, et al. Low-molecular-weight proteinuria in Chinese herbs nephropathy. Kidney Int 1995;48:1571-1576.
105. Kabanda A, Vandercam B, Bernard A, et al. Low molecular weight proteinuria in human immunodeficiency virus-infected patients. Am J Kidney Dis 1996;27:803-808.
106. Nakai K, Kikuchi M, Omori S, et al. [Evaluation of urinary cystatin C as a marker of renal dysfunction]. Nihon Jinzo Gakkai Shi 2006;48:407-415.
107. Thielemans N, Lauwerys R, Bernard A. Competition between albumin and low-molecular-weight proteins for renal tubular uptake in experimental nephropathies. Nephron 1994;66:453-458.
108. Tkaczyk M, Nowicki M, Lukamowicz J. Increased cystatin C concentration in urine of nephrotic children. Pediatr Nephrol 2004;19:1278-1280.
109. Filler G, Lepage N. Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 2003;18:981-985.
110. Cordeiro VF, Pinheiro DC, Silva GB, Jr., et al. Comparative study of cystatin C and serum creatinine in the estimative of glomerular filtration rate in children. Clin Chim Acta 2008;391:46-50.
111. Zappitelli M, Parvex P, Joseph L, et al. Derivation and validation of cystatin C-based prediction equations for GFR in children. Am J Kidney Dis 2006;48:221-230.
112. Burkhardt H, Bojarsky G, Gretz N, et al. Creatinine clearance, Cockcroft-Gault formula and cystatin C: Estimators of true glomerular filtration rate in the elderly? Gerontology 2002;48:140-146.
113. Fanos V, Mussap M, Plebani M, et al. Cystatin C in paediatric nephrology. Present situation and prospects. Minerva Pediatr 1999;51:167-177.
114. Harmoinen A, Ylinen E, Ala-Houhala M, et al. Reference intervals for cystatin C in pre- and full-term infants and children. Pediatr Nephrol 2000;15:105-108.
115. Finney H, Newman DJ, Thakkar H, et al. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child 2000;82:71-75.
116. Baxmann AC, Ahmed MS, Marques NC, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol 2008;3:348-354.
117. Galteau MM, Guyon M, Gueguen R, et al. Determination of serum cystatin C: Biological variation and reference values. Clin Chem Lab Med 2001;39:850-857.
118. Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004;65:1416-1421.
119. Finney H, Newman DJ, Price CP. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 2000;37(Pt 1):49-59.
120. Erlandsen EJ, Randers E, Kristensen JH. Reference intervals for serum cystatin C and serum creatinine in adults. Clin Chem Lab Med 1998;36:393-397.
121. Finney H, Bates CJ, Price CP. Plasma cystatin C determinations in a healthy elderly population. Arch Gerontol Geriatr 1999;29:75-94.
122. Van Den Noortgate NJ, Janssens WH, Delanghe JR, et al. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old. J Am Geriatr Soc 2002;50:1278-1282.
123. Reinhard M, Erlandsen EJ, Randers E. Biological variation of cystatin C and creatinine. Scand J Clin Lab Invest 2009;69:831-836.
124. John GT, Fleming JJ, Talaulikar GS, et al. Measurement of renal function in kidney donors using serum cystatin C and beta(2)-microglobulin. Ann Clin Biochem 2003;40:656-658.
125. Preiss DJ, Godber IM, Lamb EJ, et al. The influence of a cooked-meat meal on estimated glomerular filtration rate. Ann Clin Biochem 2007;44:35-42.
126. Sunde K, Nilsen T, Flodin M. Performance characteristics of a cystatin C immunoassay with avian antibodies. Ups J Med Sci 2007;112:21-37.
127. Gislefoss RE, Grimsrud TK, Morkrid L. Stability of selected serum proteins after long-term storage in the Janus Serum Bank. Clin Chem Lab Med 2009;47:596-603.
128. Braun JP, Lefebvre HP, Watson ADJ. Creatinine in the dog: A review. Vet Clin Pathol 2003;32:162-179.
129. O'Connor WJ, Summerill RA. The effect of a meal of meat on glomerular filtration rate in dogs at normal urine flows. J Physiol 1976;256:81-91.
130. Mojiminiyi OA, Abdella N, George S. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus. Scand J Clin Lab Invest 2000;60:483-489.
131. Harmoinen AP, Kouri TT, Wirta OR, et al. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes. Clin Nephrol 1999;52:363-370.
132. Mussap M, Dalla Vestra M, Fioretto P, et al. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 2002;61:1453-1461.
133. Oddoze C, Morange S, Portugal H, et al. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes. Am J Kidney Dis 2001;38:310-316.
134. Herget-Rosenthal S, Marggraf G, Husing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004;66:1115-1122.
135. Herget-Rosenthal S, Poppen D, Husing J, et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004;50:552-558.
136. Ahlstrom A, Tallgren M, Peltonen S, et al. Evolution and predictive power of serum cystatin C in acute renal failure. Clin Nephrol 2004;62:344-350.
137. Royakkers A, Korevaar JC, van Suijlen JDE, et al. Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. Intensive Care Med 2011;37:493-501.
138. Soto K, Coelho S, Rodrigues B, et al. Cystatin C as a marker of acute kidney injury in the emergency department. Clin J Am Soc Nephrol 2010;5:1745-1754.
139. Coca SG, Yalavarthy R, Concato J, et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review. Kidney Int 2008;73:1008-1016.
140. Honore PM, Joannes-Boyau O, Boer W. The early biomarker of acute kidney injury: In search of the Holy Grail. Intensive Care Med 2007;33:1866-1868.
141. van Hoek I, Daminet S. Interactions between thyroid and kidney function in pathological conditions of these organ systems: A review. Gen Comp Endocrinol 2009;160:205-215.
142. Ford HC, Lim WC, Chisnall WN, et al. Renal function and electrolyte levels in hyperthyroidism: Urinary protein excretion and the plasma concentrations of urea, creatinine, uric acid, hydrogen ion and electrolytes. Clin Endocrinol 1989;30:293-301.
143. Kreisman SH, Hennessey JV. Consistent reversible elevations of serum creatinine levels in severe hypothyroidism. Arch Intern Med 1999;159:79-82.
144. Gommeren K, van Hoek I, Lefebvre HP, et al. Effect of thyroxine supplementation on glomerular filtration rate in hypothyroid dogs. J Vet Intern Med 2009;23:844-849.
145. Fricker M, Wiesli P, Brandle M, et al. Impact of thyroid dysfunction on serum cystatin C. Kidney Int 2003;63:1944-1947.
146. Jayagopal V, Keevil BG, Atkin SL, et al. Paradoxical changes in cystatin C and serum creatinine in patients with hypo- and hyperthyroidism. Clin Chem 2003;49:680-681.
147. Wiesli P, Schwegler B, Spinas GA, et al. Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta 2003;338:87-90.
148. Manetti L, Pardini E, Genovesi M, et al. Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest 2005;28:346-349.
149. Schmitt R, Bachmann S. Impact of thyroid dysfunction on serum cystatin C. Kidney Int 2003;64:1139-1140.
150. den Hollander JG, Wulkan RW, Mantel MJ, et al. Is cystatin C a marker of glomerular filtration rate in thyroid dysfunction? Clin Chem 2003;49:1558-1559.
151. Kotajima N, Yanagawa Y, Aoki T, et al. Influence of thyroid hormones and transforming growth factor-beta1 on cystatin C concentrations. J Int Med Res 2010;38:1365-1373.
152. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049-2060.
153. Shlipak MG, Katz R, Fried LF, et al. Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol 2005;45:268-271.
154. Larsson A, Helmersson J, Hansson LO, et al. Increased serum cystatin C is associated with increased mortality in elderly men. Scand J Clin Lab Invest 2005;65:301-305.
155. Koenig W, Twardella D, Brenner H, et al. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: More than simply a marker of glomerular filtration rate. Clin Chem 2005;51:321-327.
156. Hawleynelson P, Roop DR, Cheng CK, et al. Molecular cloning of mouse epidermal cystatin A and detection of regulated expression in differentiation and tumorigenesis. Mol Carcinog 1988;1:202-211.
157. Sloane BF, Moin K, Krepela E, et al. Cathepsin B and its endogenous inhibitors - The role in tumor malignancy. Cancer Metastasis Rev 1990;9:333-352.
158. Kolar Z, Jarvinen M, Negrini R. Demonstration of proteinase inhibitors cystatin A, B and C in breast cancer and in cell lines MCF-7 and ZR-75-1. Neoplasma 1989;36:185-189.
159. Sokol JP, Neil JR, Schiemann BJ, et al. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta. Breast Cancer Res 2005;7:R844-R853.
160. Sokol JP, Schiemann WP. Cystatin C antagonizes transforming growth factor signaling in normal and cancer cells. Mol Cancer Res 2004;2:183-195.
161. Strojan P, Svetic B, Smid L, et al. Serum cystatin C in patients with head and neck carcinoma. Clin Chim Acta 2004;344:155-161.
162. Demirtas S, Akan O, Can M, et al. Cystatin C can be affected by nonrenal factors: A preliminary study on leukemia. Clin Biochem 2006;39:115-118.
163. Mojiminiyi OA, Marouf R, Abdella N, et al. Serum concentration of cystatin C is not affected by cellular proliferation in patients with proliferative haematological disorders. Ann Clin Biochem 2002;39:308-310.
164. Mussap M, Plebani M. Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci 2004;41:467-550.
165. Xu Y, Schnorrer P, Proietto A, et al. IL-10 controls cystatin C synthesis and blood concentration in response to inflammation through regulation of IFN regulatory factor 8 expression. J Immunol 2011;186:3666-3673.
166. Keller CR, Odden MC, Fried LF, et al. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: The health, aging, and body composition study. Kidney Int 2007;71:239-244.
167. Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009;75:652-660.
168. Bjarnadottir M, Grubb A, Olafsson I. Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest 1995;55:617-623.
169. Bokenkamp A, van Wijk JAE, Lentze MJ, et al. Effect of corticosteroid therapy on serum cystatin C and beta(2)-microglobulin concentrations. Clin Chem 2002;48:1123-1126.
170. Risch L, Herklotz R, Blumberg A, et al. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 2001;47:2055-2059.
171. Pasa S, Kilic N, Atasoy A, et al. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill dogs. J Anim Vet Adv 2008;7:1410-1412.
172. Fried LF, Biggs ML, Shlipak MG, et al. Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol 2007;18:282-286.
173. de Scally MP, Leisewitz AL, Lobetti RG, et al. The elevated serum urea: Creatinine ratio in canine babesiosis in South Africa is not of renal origin. J S Afr Vet Assoc-Tydskr Suid-Afr Vet Ver 2006;77:175-178.
174. Poli A, Abramo F, Mancianti F, et al. Renal involvement in canine Leishmaniasis - A light-microscopic, immunohistochemical and electron-microscopic study. Nephron 1991;57:444-452.
175. El-Shafey EM, El-Nagar GF, Selim MF, et al. Is serum cystatin C an accurate endogenous marker of glomerular filtration rate for detection of early renal impairment in patients with type 2 diabetes mellitus? Ren Fail 2009;31:355-359.
176. Jepson RE, Slater L, Nash S, et al. Evaluation of cystatin C as a marker of GFR in hyperthyroid cats. J Vet Intern Med 2006;20:740.
177. Bokenkamp A, Domanetzki M, Zinck R, et al. Reference values for cystatin C serum concentrations in children. Pediatr Nephrol 1998;12:125-129.